Immune evasion by cancer stem cells

Regenerative Therapy - Tập 17 - Trang 20-33 - 2021
Hiroyuki Tsuchiya1, Goshi Shiota1
1Division of Medical Genetics and Regenerative Medicine, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan

Tài liệu tham khảo

Procaccio, 2019, Safety and tolerability of anti-angiogenic protein kinase inhibitors and vascular-disrupting agents in cancer: focus on gastrointestinal malignancies, Drug Saf, 42, 159, 10.1007/s40264-018-0776-6

Kudo, 2018, Systemic therapy for hepatocellular carcinoma: latest advances, Cancers, 10, 412, 10.3390/cancers10110412

Liu, 2018, Cancer-associated fibroblasts build and secure the tumor microenvironment, Front Cell Dev Biol, 10, E412

Chanmee, 2014, Tumor-associated macrophages as major players in the tumor microenvironment, Cancers, 6, 1670, 10.3390/cancers6031670

Mishalian, 2013, Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression, Cancer Immunol Immunother, 62, 1745, 10.1007/s00262-013-1476-9

Schreiber, 2011, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486

Chantrain, 2016, Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases, Eur J Canc, 42, 310, 10.1016/j.ejca.2005.11.010

Paolillo, 2019, Extracellular matrix alterations in metastatic processes, Int J Mol Sci, 20, 4947, 10.3390/ijms20194947

Nejman, 2020, The human tumor microbiome is composed of tumor type–specific intracellular bacteria, Science, 368, 973, 10.1126/science.aay9189

Gao, 2017, Cell culture system for analysis of genetic heterogeneity within hepatocellular carcinomas and response to pharmacologic agents, Gastroenterology, 152, 232, 10.1053/j.gastro.2016.09.008

Huang, 2017, Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma, J Hepatol, 67, 293, 10.1016/j.jhep.2017.03.005

Zheng, 2018, Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma, Hepatology, 68, 127, 10.1002/hep.29778

Wang, 2014, Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts, PloS One, 9

Yang, 2007, Immunology of stem cells and cancer stem cells, Cell Mol Immunol, 4, 161

Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A, 100, 3983, 10.1073/pnas.0530291100

Quintana, 2008, Efficient tumour formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567

Quintana, 2010, Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized, Canc Cell, 18, 510, 10.1016/j.ccr.2010.10.012

Civenni, 2011, Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth, Canc Res, 71, 3098, 10.1158/0008-5472.CAN-10-3997

Rountree, 2009, Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice, Stem Cell, 27, 290, 10.1634/stemcells.2008-0332

Schatton, 2009, Antitumor immunity and cancer stem cells, Ann N Y Acad Sci, 1176, 154, 10.1111/j.1749-6632.2009.04568.x

Ma, 2010, Tumor initiation in human malignant melanoma and potential cancer therapies, Anticancer Agents Med Chem, 10, 131, 10.2174/187152010790909254

Kim, 2009, Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation, J Neurosci Res, 87, 2264, 10.1002/jnr.22050

Ljujic, 2013, Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice, Sci Rep, 3, 2298, 10.1038/srep02298

Wang, 2016, HepG2 cells acquire stem cell-like characteristics after immune cell stimulation, Cell Oncol, 39, 35, 10.1007/s13402-015-0249-1

Santisteban, 2009, Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells, Canc Res, 69, 2887, 10.1158/0008-5472.CAN-08-3343

Reim, 2009, Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells, Canc Res, 69, 8058, 10.1158/0008-5472.CAN-09-0834

Golan, 2018, In Vivo expansion of cancer stemness affords novel cancer stem cell targets: malignant rhabdoid tumor as an example, Stem Cell Reports, 11, 795, 10.1016/j.stemcr.2018.07.010

Irvin, 2010, T cells enhance stem-like properties and conditional malignancy in gliomas, PloS One, 5, 10.1371/journal.pone.0010974

Bruttel, 2014, Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?, Front Immunol, 5, 360, 10.3389/fimmu.2014.00360

Ignatius, 2009, Zebrafish as a model for cancer self-renewal, Zebrafish, 6, 377, 10.1089/zeb.2009.0610

Albini, 2015, Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity, Connect Tissue Res, 56, 414, 10.3109/03008207.2015.1066780

Hasegawa, 2015, An immunocompetent mouse model for MLL/AF9 leukemia reveals the potential of spontaneous cytotoxic T-cell response to an antigen expressed in leukemia cells, PloS One, 10, 10.1371/journal.pone.0144594

Xu, 2018, Cancer stemness, immune cells, and epithelial-mesenchymal transition cooperatively predict prognosis in colorectal carcinoma, Clin Colorectal Canc, 17, e579, 10.1016/j.clcc.2018.05.007

Sang, 2020, Human hepatic cancer stem cells (HCSCs) markers correlated with immune infiltrates reveal prognostic significance of hepatocellular carcinoma, Front Genet, 11, 112, 10.3389/fgene.2020.00112

Koyama, 2020, NEAT1 is required for the expression of the liver cancer stem cell marker CD44, Int J Mol Sci, 21, 1927, 10.3390/ijms21061927

Ramgolam, 2011, Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function, PloS One, 6, 10.1371/journal.pone.0018784

Iovino, 2011, Immunotherapy targeting colon cancer stem cells, Immunotherapy, 3, 97, 10.2217/imt.10.87

Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3

Agudo, 2018, Quiescent tissue stem cells evade immune surveillance, Immunity, 48, 271, 10.1016/j.immuni.2018.02.001

Di Tomaso, 2010, Immunobiological characterization of cancer stem cells isolated from glioblastoma patients, Clin Canc Res, 16, 800, 10.1158/1078-0432.CCR-09-2730

Wei, 2010, Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway, Mol Canc Therapeut, 9, 67, 10.1158/1535-7163.MCT-09-0734

Chikamatsu, 2011, Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck, Head Neck, 33, 208, 10.1002/hed.21420

Liao, 2013, Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines, J Canc Res Clin Oncol, 139, 159, 10.1007/s00432-012-1311-2

Sultan, 2018, Epigenetic silencing of TAP1 in Aldefluor+ breast cancer stem cells contributes to their enhanced immune evasion, Stem Cell, 36, 641, 10.1002/stem.2780

Espinoza-Sánchez, 2017, Evidence of lateral transmission of aggressive features between different types of breast cancer cells, Int J Oncol, 51, 1482, 10.3892/ijo.2017.4128

Tsuchiya, 2021, Clinical and biological implications of cancer stem cells in hepatocellular carcinoma, Yonago Acta Med, 64, 1, 10.33160/yam.2021.02.002

Morrison, 2018, Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells, BMC Canc, 18, 469, 10.1186/s12885-018-4389-3

Busse, 2013, Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?, Clin Exp Metastasis, 30, 781, 10.1007/s10585-013-9578-5

Zagzag, 2005, Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain, Lab Invest, 85, 328, 10.1038/labinvest.3700233

Palesch, 2016, Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells, Cancer Immunol Immun, 65, 283, 10.1007/s00262-016-1798-5

Girouard, 2011, Melanoma stem cells: not rare, but well done, Lab Invest, 91, 647, 10.1038/labinvest.2011.50

Schatton, 2010, Modulation of T-cell activation by malignant melanoma initiating cells, Canc Res, 70, 697, 10.1158/0008-5472.CAN-09-1592

Boiko, 2010, Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161

Chen, 2020, Synthetic and immunological studies on the OCT4 immunodominant motif antigen-based anti-cancer vaccine, Cancer Biol Med, 17, 132, 10.20892/j.issn.2095-3941.2019.0224

Di, 2013, Aiming to immune elimination of ovarian cancer stem cells, World J Stem Cell, 5, 149, 10.4252/wjsc.v5.i4.149

Di, 2013, Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patients, OncoImmunology, 2, 10.4161/onci.24271

Atakan, 2014, Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer, BMC Clin Pathol, 14, 24, 10.1186/1472-6890-14-24

Shih, 2014, Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patients, Am J Clin Exp Immunol, 3, 84

Spisek, 2007, Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy, J Exp Med, 204, 831, 10.1084/jem.20062387

Kato, 2019, Anti-CD133 monoclonal antibody CMab-43 exerts antitumor activity in a mouse xenograft model of colon cancer, Monoclon Antib Immunodiagn Immunother, 38, 75, 10.1089/mab.2019.0002

Ji, 2014, Identification of novel human leukocyte antigen-A∗0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy, Stem Cells Transl Med, 3, 356, 10.5966/sctm.2013-0135

Du, 2013, Effects and mechanisms of anti-CD44 monoclonal antibody A3D8 on proliferation and apoptosis of sphere-forming cells with stemness from human ovarian cancer, Int J Gynecol Canc, 23, 1367, 10.1097/IGC.0b013e3182a1d023

Jin, 2006, Targeting of CD44 eradicates human acute myeloid leukemic stem cells, Nat Med, 12, 1167, 10.1038/nm1483

Salnikov, 2013, Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas, Br J Canc, 108, 1449, 10.1038/bjc.2013.102

Jäger, 2012, Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3), Canc Res, 72, 24, 10.1158/0008-5472.CAN-11-2235

Kubo, 2018, Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines, Anticancer Res, 38, 4273, 10.21873/anticanres.12724

Sato, 2009, Molecular pathological approaches to human tumor immunology, Pathol Int, 59, 205, 10.1111/j.1440-1827.2009.02353.x

Tallerico, 2016, A new biological feature of natural killer cells: the recognition of solid tumor-derived cancer stem cells, Front Immunol, 7, 179, 10.3389/fimmu.2016.00179

Klingemann, 2013, Cellular therapy of cancer with natural killer cells-where do we stand?, Cytotherapy, 15, 1185, 10.1016/j.jcyt.2013.03.011

Jewett, 2012, Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells, Curr Drug Deliv, 9, 5, 10.2174/156720112798375989

Koh, 2012, Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells, Biochem Biophys Res Commun, 427, 373, 10.1016/j.bbrc.2012.09.067

Ames, 2015, NK cells preferentially target tumor cells with a cancer stem cell phenotype, J Immunol, 195, 4010, 10.4049/jimmunol.1500447

Vrazo, 2015, Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells, Blood, 126, e1, 10.1182/blood-2015-03-632273

Sussman, 2007, Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4, Canc Biol Ther, 6, 1490, 10.4161/cbt.6.9.4905

Li, 2012, Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways, Cancer Immunol Immunother, 61, 1255, 10.1007/s00262-012-1200-1

Gras Navarro, 2015, Therapeutic potential and challenges of natural killer cells in treatment of solid tumors, Front Immunol, 6, 202, 10.3389/fimmu.2015.00202

Tallerico, 2013, Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules, J Immunol, 190, 2381, 10.4049/jimmunol.1201542

Cristiani, 2019, Accumulation of circulating CCR7+ natural killer cells marks melanoma evolution and reveals a CCL19-dependent metastatic pathway, Cancer Immunol Res, 7, 841, 10.1158/2326-6066.CIR-18-0651

Castriconi, 2007, Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity, Eur J Immunol, 37, 3190, 10.1002/eji.200737546

Oh, 2017, Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand, Canc Cell Int, 17, 22, 10.1186/s12935-017-0397-7

Avril, 2012, Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells, Brain Pathol, 22, 159, 10.1111/j.1750-3639.2011.00515.x

Castriconi, 2009, NK cells recognize and kill human glioblastoma cells with stem cell-like properties, J Immunol, 182, 3530, 10.4049/jimmunol.0802845

Iwaszko, 2011, Clinical significance of the HLA-E and CD94/NKG2 interaction, Arch Immunol Ther Exp, 59, 353, 10.1007/s00005-011-0137-y

Melaiu, 2020, Influence of the tumor microenvironment on NK cell function in solid tumors, Front Immunol, 10, 3038, 10.3389/fimmu.2019.03038

Introna, 2017, CIK as therapeutic agents against tumors, J Autoimmun, 85, 32, 10.1016/j.jaut.2017.06.008

Sangiolo, 2014, Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas, Canc Res, 74, 119, 10.1158/0008-5472.CAN-13-1559

Wei, 2015, Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition, Oncotarget, 6, 35023, 10.18632/oncotarget.5280

Li, 2012, Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma, J Immunother, 35, 189

Ren, 2013, Clin Transl Oncol, 15, 780, 10.1007/s12094-013-1001-9

Xie, 2017, Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment, World J Surg Oncol, 15, 209, 10.1186/s12957-017-1278-1

Mai, 2018, Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy, J Canc Res Therapeut, 14, S427, 10.4103/0973-1482.180609

Contag, 2010, Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cells, Canc Res, 70, 9837, 10.1158/0008-5472.CAN-10-2650

Gammaitoni, 2013, Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features, Clin Canc Res, 19, 4347, 10.1158/1078-0432.CCR-13-0061

Gammaitoni, 2017, Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells, Clin Canc Res, 23, 2277, 10.1158/1078-0432.CCR-16-1524

Yang, 2018, Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system, BMC Canc, 18, 984, 10.1186/s12885-018-4871-y

Miyatake, 2013, Protective roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells, Am J Pathol, 182, 1832, 10.1016/j.ajpath.2013.01.015

Park, 2019, The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance, J Exp Clin Canc Res, 38, 399, 10.1186/s13046-019-1405-7

Bedel, 2011, Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells, Canc Res, 71, 1615, 10.1158/0008-5472.CAN-09-4540

Akhter, 2018, Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype, Oncogene, 37, 2089, 10.1038/s41388-017-0106-y

Zhong, 2010, Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells, Canc Lett, 299, 150, 10.1016/j.canlet.2010.08.013

Amiot, 2011, Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?, Cell Mol Life Sci, 68, 417, 10.1007/s00018-010-0583-4

Kochan, 2013, Role of non-classical MHC class I molecules in cancer immunosuppression, OncoImmunology, 2, 10.4161/onci.26491

Pende, 2019, Killer ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation, Front Immunol, 10, 1179, 10.3389/fimmu.2019.01179

Özgül Özdemir, 2016, A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues, Ann Diagn Pathol, 25, 60, 10.1016/j.anndiagpath.2016.09.012

Wolpert, 2012, HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells, J Neuroimmunol, 250, 27, 10.1016/j.jneuroim.2012.05.010

Teklemariam, 2012, Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization, Hum Immunol, 73, 898, 10.1016/j.humimm.2012.06.007

Grange, 2015, Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation, BMC Canc, 15, 1009, 10.1186/s12885-015-2025-z

da Silva, 2017, Qa-2 expression levels is related with tumor-infiltrating lymphocytes profile during solid Ehrlich tumor development, Biomed Pharmacother, 92, 750, 10.1016/j.biopha.2017.05.135

Henrich-Noack, 2017, Electrical brain stimulation induces dendritic stripping but improves survival of silent neurons after optic nerve damage, Sci Rep, 7, 627, 10.1038/s41598-017-00487-z

Keefe, 2005, Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis, Immunity, 23, 249, 10.1016/j.immuni.2005.08.001

Chowdhury, 2008, Death by a thousand cuts: granzyme pathways of programmed cell death, Annu Rev Immunol, 26, 389, 10.1146/annurev.immunol.26.021607.090404

Lauricella, 2016, The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: possible regulatory mechanisms, Int J Oncol, 49, 352, 10.3892/ijo.2016.3495

Raja, 2005, A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cells, J Biol Chem, 280, 20752, 10.1074/jbc.M501181200

Roy, 2017, Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression, Oncotarget, 8, 24815, 10.18632/oncotarget.15820

Ahrens, 2020, The role of proteoglycans in cancer metastasis and circulating tumor cell analysis, Front Cell Dev Biol, 8, 749, 10.3389/fcell.2020.00749

Matsukuma, 2016, Calreticulin is highly expressed in pancreatic cancer stem-like cells, Canc Sci, 107, 1599, 10.1111/cas.13061

Andrin, 1998, Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules, Biochemistry, 37, 10386, 10.1021/bi980595z

Fraser, 2000, Perforin lytic activity is controlled by calreticulin, J Immunol, 164, 4150, 10.4049/jimmunol.164.8.4150

Wijeyesakere, 2016, The C-terminal acidic region of calreticulin mediates phosphatidylserine binding and apoptotic cell phagocytosis, J Immunol, 196, 3896, 10.4049/jimmunol.1502122

Feng, 2018, Programmed cell removal by calreticulin in tissue homeostasis and cancer, Nat Commun, 9, 3194, 10.1038/s41467-018-05211-7

Tan, 2009, Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?, Breast Canc Res Treat, 115, 453, 10.1007/s10549-008-0184-1

Padua, 2009, Roles of TGFbeta in metastasis, Cell Res, 19, 89, 10.1038/cr.2008.316

Shipitsin, 2007, Molecular definition of breast tumor heterogeneity, Canc Cell, 11, 259, 10.1016/j.ccr.2007.01.013

Chng, 2010, SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells, Cell Stem Cell, 6, 59, 10.1016/j.stem.2009.11.015

Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027

Cufí, 2010, Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis, Cell Cycle, 9, 4461, 10.4161/cc.9.22.14048

Vazquez-Martin, 2010, Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status, Cell Cycle, 9, 3807, 10.4161/cc.9.18.13131

Lottaz, 2010, Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin, Canc Res, 70, 2030, 10.1158/0008-5472.CAN-09-1707

AlHossiny, 2016, Ly6E/K signaling to TGFβ promotes breast cancer progression, immune escape, and drug resistance, Canc Res, 76, 3376, 10.1158/0008-5472.CAN-15-2654

Dziurzynski, 2011, Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype, Clin Canc Res, 17, 4642, 10.1158/1078-0432.CCR-11-0414

Lee, 2004, Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients, J Immunol, 172, 7335, 10.4049/jimmunol.172.12.7335

Facoetti, 2005, Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors, Clin Canc Res, 11, 8304, 10.1158/1078-0432.CCR-04-2588

Zhong, 2019, Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells, BMC Canc, 19, 439, 10.1186/s12885-019-5670-9

Jo, 2010, Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells, Canc Res, 70, 8948, 10.1158/0008-5472.CAN-10-1936

Hu, 2014, uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages, Am J Pathol, 184, 3384, 10.1016/j.ajpath.2014.08.003

Sainz, 2015, Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment, Gut, 64, 1921, 10.1136/gutjnl-2014-308935

Liu, 2015, IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation, Int J Canc, 136, 547, 10.1002/ijc.29033

Korkaya, 2011, Breast cancer stem cells, cytokine networks, and the tumor microenvironment, J Clin Invest, 121, 3804, 10.1172/JCI57099

Balamurugan, 2019, C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes, Oncogene, 38, 3765, 10.1038/s41388-018-0516-5

Wu, 2019, Effect of tumor burden on tumor aggressiveness and immune modulation in prostate cancer: association with IL-6 signaling, Cancers, 11, 992, 10.3390/cancers11070992

Yang, 2017, The KMT1A-GATA3-STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells, Clin Canc Res, 23, 6673, 10.1158/1078-0432.CCR-17-0882

Lee, 2016, CD44+ cells in head and neck squamous cell carcinoma suppress T-cell-mediated immunity by selective constitutive and inducible expression of PD-L1, Clin Canc Res, 22, 3571, 10.1158/1078-0432.CCR-15-2665

Chen, 2018, CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer, PLoS Biol, 16, 10.1371/journal.pbio.2005869

Chen, 2011, Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis, PloS One, 6

Chen, 2013, High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma, Oncol Rep, 30, 1380, 10.3892/or.2013.2603

Zhang, 2015, The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients, Biomed Pharmacother, 69, 242, 10.1016/j.biopha.2014.12.008

Lian, 2020, Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway, Canc Sci

Maccalli, 2014, Immunology of cancer stem cells in solid tumours. A review, Eur J Canc, 50, 649, 10.1016/j.ejca.2013.11.014

Parsa, 2007, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, Nat Med, 13, 84, 10.1038/nm1517

Yang, 2015, B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor, Oncol Lett, 9, 1833, 10.3892/ol.2015.2949

Polónia, 2017, Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer, J Clin Pathol, 70, 860, 10.1136/jclinpath-2016-203990

Inaguma, 2018, Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma, Hum Pathol, 71, 1, 10.1016/j.humpath.2017.04.032

Jinesh, 2017, Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis, Sci Rep, 7, 9602, 10.1038/s41598-017-08796-z

Terzuoli, 2019, ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output, Cancers, 11, 1963, 10.3390/cancers11121963

Hou, 2019, Low CD8⁺ T cell infiltration and high PD-L1 expression are associated with level of CD44⁺/CD133⁺ cancer stem cells and predict an unfavorable prognosis in pancreatic cancer, Cancers, 11, 541, 10.3390/cancers11040541

Yi, 2017, PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer, Exp Cell Res, 358, 87, 10.1016/j.yexcr.2017.05.017

Tsai, 2017, Epigenetic therapy regulates the expression of ALDH1 and immunologic response: relevance to the prognosis of oral cancer, Oral Oncol, 73, 88, 10.1016/j.oraloncology.2017.08.007

Wei, 2019, PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways, Canc Lett, 450, 1, 10.1016/j.canlet.2019.02.022

Liao, 2020, Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer, Theranostics, 10, 6095, 10.7150/thno.44147

Chen, 2019, Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells, BMC Canc, 19, 153, 10.1186/s12885-019-5364-3

Hossain, 2014, Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity, Blood, 123, 15, 10.1182/blood-2013-07-517987

Wang, 2020, Acetylcholine promotes the self-renewal and immune escape of CD133+ thyroid cancer cells through activation of CD133-Akt pathway, Canc Lett, 471, 116, 10.1016/j.canlet.2019.12.009

Wilson, 2013, Blockade of chronic type I interferon signaling to control persistent LCMV infection, Science, 340, 202, 10.1126/science.1235208

Teijaro, 2013, Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, 340, 207, 10.1126/science.1235214

Ayers, 2017, IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade, J Clin Invest, 127, 2930, 10.1172/JCI91190

Furuta, 2014, CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens, J Invest Dermatol, 134, 1369, 10.1038/jid.2013.490

Fujii, 2016, Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab, Oncotarget, 7, 33498, 10.18632/oncotarget.9256

Gross, 2018, Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas, OncoImmunology, 8

Zhu, 2014, Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells, Exp Cell Res, 324, 146, 10.1016/j.yexcr.2014.03.020

Sainz, 2014, ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells, Canc Res, 74, 7309, 10.1158/0008-5472.CAN-14-1354

Song, 2019, Low-Dose IFNγ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer, Canc Res, 79, 3737, 10.1158/0008-5472.CAN-19-0596

Castiello, 2018, Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells, Cancer Immunol Res, 6, 658, 10.1158/2326-6066.CIR-17-0675

Li, 2016, CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy, BMC Canc, 16, 15, 10.1186/s12885-016-2050-6

Zelenay, 2015, Cyclooxygenase-dependent tumor growth through evasion of immunity, Cell, 162, 1257, 10.1016/j.cell.2015.08.015

Celià-Terrassa, 2017, Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis, Nat Cell Biol, 19, 711, 10.1038/ncb3533

Zhan, 2020, Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation, J Exp Med, 217, 10.1084/jem.20191340

Barclay, 2002, CD200 and membrane protein interactions in the control of myeloid cells, Trends Immunol, 23, 285, 10.1016/S1471-4906(02)02223-8

Kawasaki, 2008, Cancer stem cells, CD200 and immunoevasion, Trends Immunol, 29, 464, 10.1016/j.it.2008.07.005

Kawasaki, 2007, Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells, Biochem Biophys Res Commun, 364, 778, 10.1016/j.bbrc.2007.10.067

Ho, 2020, CD200 expression marks leukemia stem cells in human AML, Blood Adv, 4, 5402, 10.1182/bloodadvances.2020001802

Jung, 2015, CD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma, Head Neck, 37, 327, 10.1002/hed.23608

Tonks, 2007, CD200 as a prognostic factor in acute myeloid leukaemia, Leukemia, 21, 566, 10.1038/sj.leu.2404559

Wong, 2010, The role of CD200 in immunity to B cell lymphoma, J Leukoc Biol, 88, 361, 10.1189/jlb.1009686

Gilson, 2019, Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling, Prog Lipid Res, 76, 101010, 10.1016/j.plipres.2019.101010

Chung, 2015, Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin, Oncotarget, 6, 4936, 10.18632/oncotarget.3210

Caputo, 2020, Galectin-3 in prostate cancer stem-like cells is immunosuppressive and drives early metastasis, Front Immunol, 11, 1820, 10.3389/fimmu.2020.01820

van der Touw, 2017, LILRB receptor-mediated regulation of myeloid cell maturation and function, Cancer Immunol Immunother, 66, 1079, 10.1007/s00262-017-2023-x

Zheng, 2012, Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development, Nature, 485, 656, 10.1038/nature11095

Liu, 2015, ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells, Oncotarget, 6, 21004, 10.18632/oncotarget.4217

Su, 2020, Targeting FTO suppresses cancer stem cell maintenance and immune evasion, Canc Cell, 38, 79, 10.1016/j.ccell.2020.04.017

Sica, 2017, Tumor-associated myeloid cells as guiding forces of cancer cell stemness, Cancer Immunol Immunother, 66, 1025, 10.1007/s00262-017-1997-8

Abdullah, 2013, Mechanisms of chemoresistance in cancer stem cells, Clin Transl Med, 2, 3, 10.1186/2001-1326-2-3

Ni, 2014, Cancer stem cells in prostate cancer chemoresistance, Curr Cancer Drug Targets, 14, 225, 10.2174/1568009614666140328152459

Noh, 2014, API5 confers tumoral immune escape through FGF2-dependent cell survival pathway, Canc Res, 74, 3556, 10.1158/0008-5472.CAN-13-3225

Song, 2017, API5 confers cancer stem cell-like properties through the FGF2-NANOG axis, Oncogenesis, 6, e285, 10.1038/oncsis.2016.87

Wu, 2010, Glioma cancer stem cells induce immunosuppressive macrophages/microglia, Neuro Oncol, 12, 1113, 10.1093/neuonc/noq082

Noh, 2012, Nanog signaling in cancer promotes stem-like phenotype and immune evasion, J Clin Invest, 122, 4077, 10.1172/JCI64057

Noh, 2012, Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype, Canc Res, 72, 1717, 10.1158/0008-5472.CAN-11-3758

Chen, 2017, CD59 regulation by SOX2 is required for epithelial cancer stem cells to evade complement surveillance, Stem Cell Reports, 8, 140, 10.1016/j.stemcr.2016.11.008

Wu, 2020, Cancer stem cell marker DCLK1 correlates with tumorigenic immune infiltrates in the colon and gastric adenocarcinoma microenvironments, Cancers, 12, 274, 10.3390/cancers12020274

Yan, 2020, Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer, Life Sci, 241, 117150, 10.1016/j.lfs.2019.117150

Beavis, 2013, Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors, Proc Natl Acad Sci U S A, 110, 14711, 10.1073/pnas.1308209110

Katsuta, 2016, CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells, Int J Oncol, 48, 657, 10.3892/ijo.2015.3299

Thông tin
Thông tin xuất bản

Regenerative Therapy

Tập 17

20-33

Thông tin tác giả